FDA website for adverse event reports will encourage public participation
This article was originally published in Clinica
The US FDA is developing a dedicated website that will serve as the sole repository for information about safety problems with medical devices, drugs, biologics, animal health products and food. The agency's plans were disclosed last week by deputy FDA commissioner Scott Gottlieb during a speech to a Bank of America healthcare conference in Washington. "The system will be easy to use so that the general public is encouraged to report incidents and is not deterred by the nature of the information requested," he explained. "Once collected, the consolidated information will make it easier for us to develop robust tools for screening reports."
You may also be interested in...
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.